Infectious Disease Diagnostic Market, By Product & Service (Reagents, Kits, And Consumables, Instruments, and Software & Services), By Type of Testing, By Sample Type, By Disease Type, By Technology, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
|
Report ID
AV4078
|
Published Date
June 2025
|
Pages
399
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Infectious Disease Diagnostic Market size was valued at USD 22,918 Million in 2024, expanding at a CAGR of 8.2% from 2024 to 2032.
Infectious Disease Diagnostics encompass the processes and techniques used to detect, identify, and confirm the presence of pathogens—such as bacteria, viruses, fungi, or parasites—that cause infectious diseases in humans and animals. This diagnostic approach involves a range of methods, including laboratory tests like culture, microscopy, molecular assays (e.g., PCR), antigen detection, and serological analysis. Accurate and timely diagnostics are essential for guiding appropriate treatment, implementing infection control measures, and supporting epidemiological surveillance. By accurately identifying infectious agents, monitoring disease progression, and informing public health strategies, infectious disease diagnostics play a vital role in preventing outbreaks and ensuring effective patient management.
Infectious Disease Diagnostic Market- Market Dynamics
Rising Incidence of Infectious Diseases
The growing incidence of infectious diseases worldwide is a major driver of the infectious disease diagnostics market. Factors such as increasing population density, global travel, and climate change contribute to the accelerated spread of pathogens. Moreover, the rise of antibiotic-resistant strains and the emergence of new infectious agents have heightened the demand for accurate and rapid diagnostic tools. Early and precise diagnosis facilitates timely treatment, helping to reduce transmission rates and improve patient outcomes. As a result, healthcare systems are increasingly investing in advanced diagnostic technologies, driving growth and innovation in infectious disease detection and management.
Globally, governments and organizations like the World Health Organization (WHO) are prioritizing infectious disease control by funding diagnostic infrastructure and research. For example, the U.S. government has allocated substantial resources through the CDC to enhance diagnostic capabilities, while the European Union’s Horizon Europe program invests heavily in combating infectious diseases. These policy initiatives and funding efforts underscore the critical role of diagnostics in global health security and support sustained market expansion.
Infectious Disease Diagnostic Market- Segmentation Analysis:
The global Infectious Disease Diagnostic Market is divided into Seven categories: Product & Service, End User, Type of Testing, Sample Type, Disease Type, Technology, and Region.
The infectious disease diagnostics market is segmented by product and service into three main categories: reagents, kits, and consumables; instruments; and software & services. Among these, reagents, kits, and consumables dominate the market due to their continuous and recurring demand in laboratories and hospitals for routine diagnostic testing. These components include essential chemicals, test kits, and materials crucial for ensuring test accuracy and reliability. Their high consumption rate, driven by the need for frequent infectious disease screening, makes this segment a primary revenue driver. According to the U.S. Centers for Disease Control and Prevention (CDC), government funding for infectious disease diagnostics and laboratory preparedness has increased by over 20% in recent years, reflecting the critical role of reagents and consumables in managing public health.
The infectious disease diagnostics market is also categorized by technology into several key segments, including immunodiagnostics, clinical microbiology, polymerase chain reaction (PCR), isothermal nucleic acid amplification technology, DNA sequencing & next-generation sequencing (NGS), DNA microarray, and other emerging technologies. Among these, PCR holds the dominant position due to its high sensitivity, specificity, rapid turnaround time, and widespread clinical adoption worldwide. PCR technology amplifies pathogen DNA or RNA, enabling precise and early detection of infectious agents. Other molecular techniques like isothermal amplification and NGS offer advanced diagnostic capabilities, but PCR remains the preferred choice for many laboratories. Government initiatives such as the National Institutes of Health (NIH) increased funding for molecular diagnostics research by nearly 18% in the past five years, supporting the adoption and advancement of PCR and related technologies in infectious disease detection and management.
Infectious Disease Diagnostic Market- Geographical Insights
Geographically, the Infectious Disease Diagnostics Market is spread across North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa, with further segmentation based on key contributing countries.
North America holds a dominant position in the infectious disease diagnostics market, driven by its advanced healthcare infrastructure, high healthcare spending, and widespread adoption of cutting-edge diagnostic technologies. The United States leads the region due to substantial investments in research and development, strong regulatory frameworks, and the presence of major diagnostic companies. The region’s emphasis on early disease detection, the rising prevalence of infectious diseases, and growing awareness among healthcare providers further propel market growth. Government initiatives aimed at enhancing diagnostic capabilities, such as the U.S. CDC’s funding of $1.4 billion in 2023 for infectious disease preparedness and diagnostics, coupled with increasing demand for rapid point-of-care testing, also strengthen North America’s leadership in this sector.
Asia Pacific represents another crucial and rapidly expanding market for infectious disease diagnostics. This growth is fueled by a large and increasing population, expanding healthcare access, and a high burden of infectious diseases. Key countries such as China and India drive demand due to their expanding healthcare infrastructure and increased government healthcare spending. The region benefits from rising public awareness, improved diagnostic facilities, and an expanding middle class seeking better healthcare services. Additionally, recent outbreaks of infectious diseases like tuberculosis, dengue, and COVID-19 have highlighted the critical need for robust diagnostic solutions. Governments across the region, including China’s Ministry of Health and India’s National Health Mission, have increased investments in diagnostic infrastructure, further positioning Asia Pacific as a fast-growing and strategically vital market in this sector.
Infectious Disease Diagnostic Market- Competitive Landscape:
The infectious disease diagnostics market is dominated by key players such as Abbott, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., and bioMérieux. These companies lead the market with extensive product portfolios and a strong focus on continuous innovation. They invest significantly in research and development to improve diagnostic accuracy, speed, and automation while ensuring compliance with stringent regulatory standards. The competitive landscape is further enriched by emerging firms specializing in molecular diagnostics and point-of-care testing technologies. Strategic acquisitions and collaborations are frequently pursued to broaden geographic reach and enhance technological capabilities, ultimately advancing infectious disease detection and improving patient outcomes globally.
Recent Developments:
- In March 2025, Abbott launched a rapid molecular test for respiratory infections that delivers results in under 30 minutes, significantly boosting point-of-care diagnostic capabilities.
- In January 2024, Roche expanded its diagnostic portfolio with a highly sensitive multiplex assay for simultaneous detection of COVID-19 and influenza viruses, enhancing the efficiency of pathogen detection.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- F. Hoffmann-La Roche Ltd.
- Abbott
- Biomérieux
- Siemens Healthineers Ag
- Danaher
- Thermo Fisher Scientific Inc.
- Hologic, Inc.
- Becton, Dickinson And Company
- Revvity
- Qiagen
- Seegene Inc.
- Quidelortho Corporation
- Grifols, S.A.
- Diasorin S.P.A.
- Bio-Rad Laboratories, Inc.
- Sysmex Corporation
- Others
GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY PRODUCT & SERVICE - MARKET ANALYSIS, 2019 - 2032
- Reagents, Kits, And Consumables
- Instruments
- Software & Services
GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY END USER - MARKET ANALYSIS, 2019 - 2032
- Diagnostic Laboratories
- Hospitals & Clinics
- Academic Research Institutes
- Other End Users
GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY TYPE OF TESTING - MARKET ANALYSIS, 2019 - 2032
- Laboratory Testing
- POC Testing
GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY DISEASE TYPE - MARKET ANALYSIS, 2019 - 2032
- Hepatitis
- Hepatitis B
- Hepatitis C
- Other Hepatitis Diseases
- HIV
- Hospital-Acquired Infections
- Mosquito-Borne Diseases
- HPV
- Chlamydia Trachomatis
- Neisseria Gonorrhea
- Tuberculosis
- Influenza
- Syphilis
- Covid-19
- Other Infectious Diseases
GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY TECHNOLOGY - MARKET ANALYSIS, 2019 - 2032
- Immunodiagnostics
- Clinical Microbiology
- Polymerase Chain Reaction
- Isothermal Nucleic Acid Amplification Technology
- Dna Sequencing & Next-Generation Sequencing
- Dna Microarray
- Other Technologies
GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY SAMPLE TYPE - MARKET ANALYSIS, 2019 - 2032
- Blood, Serum, And Plasma
- Urine
- Other Sample Types
GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Infectious Disease Diagnostic Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Infectious Disease Diagnostic Market Snippet by Product & Service
2.1.2. Infectious Disease Diagnostic Market Snippet by Type of Testing
2.1.3. Infectious Disease Diagnostic Market Snippet by Sample Type
2.1.4. Infectious Disease Diagnostic Market Snippet by Disease Type
2.1.5. Infectious Disease Diagnostic Market Snippet by Technology
2.1.6. Infectious Disease Diagnostic Market Snippet by End User
2.1.7. Infectious Disease Diagnostic Market Snippet by Country
2.1.8. Infectious Disease Diagnostic Market Snippet by Region
2.2. Competitive Insights
3. Infectious Disease Diagnostic Key Market Trends
3.1. Infectious Disease Diagnostic Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Infectious Disease Diagnostic Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Infectious Disease Diagnostic Market Opportunities
3.4. Infectious Disease Diagnostic Market Future Trends
4. Infectious Disease Diagnostic Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Infectious Disease Diagnostic Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Infectious Disease Diagnostic Market Landscape
6.1. Infectious Disease Diagnostic Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Infectious Disease Diagnostic Market – By Product & Service
7.1. Overview
7.1.1. Segment Share Analysis, By Product & Service, 2023 & 2032 (%)
7.1.2. Reagents, Kits, And Consumables
7.1.3. Instruments
7.1.4. Software & Services
8. Infectious Disease Diagnostic Market – By Type of Testing
8.1. Overview
8.1.1. Segment Share Analysis, By Type of Testing, 2023 & 2032 (%)
8.1.2. Laboratory Testing
8.1.3. POC Testing
9. Infectious Disease Diagnostic Market – By Sample Type
9.1. Overview
9.1.1. Segment Share Analysis, By Sample Type, 2023 & 2032 (%)
9.1.2. Blood, Serum, And Plasma
9.1.3. Urine
9.1.4. Other Sample Types
10. Infectious Disease Diagnostic Market – By Disease Type
10.1. Overview
10.1.1. Segment Share Analysis, By Disease Type, 2023 & 2032 (%)
10.1.2. Hepatitis
10.1.2.1. Hepatitis B
10.1.2.2. Hepatitis C
10.1.2.3. Other Hepatitis Diseases
10.1.3. HIV
10.1.4. Hospital-Acquired Infections
10.1.5. Mosquito-Borne Diseases
10.1.6. HPV
10.1.7. Chlamydia Trachomatis
10.1.8. Neisseria Gonorrhea
10.1.9. Tuberculosis
10.1.10. Influenza
10.1.11. Syphilis
10.1.12. Covid-19
10.1.13. Other Infectious Diseases
11. Infectious Disease Diagnostic Market – By Technology
11.1. Overview
11.1.1. Segment Share Analysis, By Technology, 2023 & 2032 (%)
11.1.2. Immunodiagnostics
11.1.3. Clinical Microbiology
11.1.4. Polymerase Chain Reaction
11.1.5. Isothermal Nucleic Acid Amplification Technology
11.1.6. DNA Sequencing & Next-Generation Sequencing
11.1.7. DNA Microarray
11.1.8. Other Technologies
12. Infectious Disease Diagnostic Market – By End User
12.1. Overview
12.1.1. Segment Share Analysis, By Technology, 2023 & 2032 (%)
12.1.2. Diagnostic Laboratories
12.1.3. Hospitals & Clinics
12.1.4. Academic Research Institutes
12.1.5. Other End Users
13. Infectious Disease Diagnostic Market– By Geography
13.1. Introduction
13.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
13.2. North America
13.2.1. Overview
13.2.2. Infectious Disease Diagnostic Key Manufacturers in North America
13.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
13.2.4. North America Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
13.2.5. North America Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
13.2.6. North America Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
13.2.7. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
13.2.8. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.2.9. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.2.10. U.S.
13.2.10.1. Overview
13.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.2.10.3. U.S. Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
13.2.10.4. U.S. Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
13.2.10.5. U.S. Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
13.2.10.6. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
13.2.10.7. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.2.10.8. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.2.11. Canada
13.2.11.1. Overview
13.2.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.2.11.3. Canada Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
13.2.11.4. Canada Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
13.2.11.5. Canada Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
13.2.11.6. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
13.2.11.7. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.2.11.8. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.3. Europe
13.3.1. Overview
13.3.2. Infectious Disease Diagnostic Key Manufacturers in Europe
13.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
13.3.4. Europe Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
13.3.5. Europe Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
13.3.6. Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
13.3.7. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
13.3.8. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.3.9. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.3.10. Germany
13.3.10.1. Overview
13.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.3.10.3. Germany Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
13.3.10.4. Germany Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
13.3.10.5. Germany Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
13.3.10.6. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
13.3.10.7. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.3.10.8. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.3.11. Italy
13.3.11.1. Overview
13.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.3.11.3. Italy Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
13.3.11.4. Italy Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
13.3.11.5. Italy Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
13.3.11.6. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
13.3.11.7. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.3.11.8. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.3.12. United Kingdom
13.3.12.1. Overview
13.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.3.12.3. United Kingdom Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
13.3.12.4. United Kingdom Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
13.3.12.5. United Kingdom Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
13.3.12.6. United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
13.3.12.7. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.3.12.8. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.3.13. France
13.3.13.1. Overview
13.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.3.13.3. France Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
13.3.13.4. France Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
13.3.13.5. France Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
13.3.13.6. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
13.3.13.7. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.3.13.8. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.3.14. Russia
13.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.3.14.2. Russia Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
13.3.14.3. Russia Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
13.3.14.4. Russia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
13.3.14.5. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
13.3.14.6. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.3.14.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.3.15. Netherlands
13.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.3.15.2. Netherlands Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
13.3.15.3. Netherlands Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
13.3.15.4. Netherlands Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
13.3.15.5. Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
13.3.15.6. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.3.15.7. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.3.16. Sweden
13.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.3.16.2. Sweden Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
13.3.16.3. Sweden Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
13.3.16.4. Sweden Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
13.3.16.5. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
13.3.16.6. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.3.16.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.3.17. Poland
13.3.17.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.3.17.2. Poland Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
13.3.17.3. Poland Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
13.3.17.4. Poland Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
13.3.17.5. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
13.3.17.6. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.3.18. Rest of Europe
13.3.18.1. Overview
13.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.3.18.3. Rest of the Europe Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
13.3.18.4. Rest of the Europe Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
13.3.18.5. Rest of the Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
13.3.18.6. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
13.3.18.7. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.3.18.8. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.4. Asia Pacific (APAC)
13.4.1. Overview
13.4.2. Infectious Disease Diagnostic Key Manufacturers in Asia Pacific
13.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
13.4.4. Asia Pacific Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
13.4.5. Asia Pacific Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
13.4.6. Asia Pacific Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
13.4.7. Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
13.4.8. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.4.9. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.4.10. India
13.4.10.1. Overview
13.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.4.10.3. India Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
13.4.10.4. India Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
13.4.10.5. India Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
13.4.10.6. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
13.4.10.7. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.4.10.8. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.4.11. China
13.4.11.1. Overview
13.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.4.11.3. China Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
13.4.11.4. China Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
13.4.11.5. China Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
13.4.11.6. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
13.4.11.7. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.4.11.8. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.4.12. Japan
13.4.12.1. Overview
13.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.4.12.3. Japan Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
13.4.12.4. Japan Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
13.4.12.5. Japan Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
13.4.12.6. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
13.4.12.7. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.4.12.8. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.4.13. South Korea
13.4.13.1. Overview
13.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.4.13.3. South Korea Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
13.4.13.4. South Korea Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
13.4.13.5. South Korea Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
13.4.13.6. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
13.4.13.7. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.4.13.8. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.4.14. Australia
13.4.14.1. Overview
13.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.4.14.3. Australia Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
13.4.14.4. Australia Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
13.4.14.5. Australia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
13.4.14.6. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
13.4.14.7. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.4.14.8. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.4.15. Thailand
13.4.15.1. Overview
13.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.4.15.3. Thailand Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
13.4.15.4. Thailand Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
13.4.15.5. Thailand Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
13.4.15.6. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
13.4.15.7. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.4.15.8. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.4.16. Indonesia
13.4.16.1. Overview
13.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.4.16.3. Indonesia Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
13.4.16.4. Indonesia Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
13.4.16.5. Indonesia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
13.4.16.6. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
13.4.16.7. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.4.16.8. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.4.17. Philippines
13.4.17.1. Overview
13.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.4.17.3. Philippines Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
13.4.17.4. Philippines Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
13.4.17.5. Philippines Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
13.4.17.6. Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
13.4.17.7. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.4.17.8. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.4.18. Rest of APAC
13.4.18.1. Overview
13.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.4.18.3. Rest of APAC Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
13.4.18.4. Rest of APAC Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
13.4.18.5. Rest of APAC Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
13.4.18.6. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
13.4.18.7. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.4.18.8. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.5. Latin America
13.5.1. Overview
13.5.2. Infectious Disease Diagnostic Key Manufacturers in Latin America
13.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
13.5.4. Latin America Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
13.5.5. Latin America Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
13.5.6. Latin America Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
13.5.7. Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
13.5.8. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.5.9. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.5.10. Brazil
13.5.10.1. Overview
13.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.5.10.3. Brazil Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
13.5.10.4. Brazil Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
13.5.10.5. Brazil Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
13.5.10.6. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
13.5.10.7. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.5.10.8. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.5.11. Mexico
13.5.11.1. Overview
13.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.5.11.3. Mexico Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
13.5.11.4. Mexico Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
13.5.11.5. Mexico Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
13.5.11.6. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
13.5.11.7. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.5.11.8. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.5.12. Argentina
13.5.12.1. Overview
13.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.5.12.3. Argentina Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
13.5.12.4. Argentina Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
13.5.12.5. Argentina Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
13.5.12.6. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
13.5.12.7. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.5.12.8. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.5.13. Colombia
13.5.13.1. Overview
13.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.5.13.3. Colombia Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
13.5.13.4. Colombia Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
13.5.13.5. Colombia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
13.5.13.6. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
13.5.13.7. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.5.13.8. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.5.14. Rest of LATAM
13.5.14.1. Overview
13.5.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.5.14.3. Rest of LATAM Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
13.5.14.4. Rest of LATAM Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
13.5.14.5. Rest of LATAM Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
13.5.14.6. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
13.5.14.7. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.5.14.8. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.6. Middle East and Africa
13.6.1. Overview
13.6.2. Infectious Disease Diagnostic Key Manufacturers in Middle East and Africa
13.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
13.6.4. Middle East and Africa Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
13.6.5. Middle East and Africa Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
13.6.6. Middle East and Africa Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
13.6.7. Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
13.6.8. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.6.9. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.6.10. Saudi Arabia
13.6.10.1. Overview
13.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.6.10.3. Saudi Arabia Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
13.6.10.4. Saudi Arabia Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
13.6.10.5. Saudi Arabia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
13.6.10.6. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
13.6.10.7. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.6.10.8. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.6.11. United Arab Emirates
13.6.11.1. Overview
13.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.6.11.3. United Arab Emirates Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
13.6.11.4. United Arab Emirates Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
13.6.11.5. United Arab Emirates Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
13.6.11.6. United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
13.6.11.7. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.6.11.8. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.6.12. Israel
13.6.12.1. Overview
13.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.6.12.3. Israel Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
13.6.12.4. Israel Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
13.6.12.5. Israel Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
13.6.12.6. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
13.6.12.7. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.6.12.8. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.6.13. Turkey
13.6.13.1. Overview
13.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.6.13.3. Turkey Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
13.6.13.4. Turkey Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
13.6.13.5. Turkey Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
13.6.13.6. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
13.6.13.7. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.6.13.8. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.6.14. Algeria
13.6.14.1. Overview
13.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.6.14.3. Algeria Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
13.6.14.4. Algeria Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
13.6.14.5. Algeria Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
13.6.14.6. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
13.6.14.7. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.6.14.8. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.6.15. Egypt
13.6.15.1. Overview
13.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.6.15.3. Egypt Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
13.6.15.4. Egypt Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
13.6.15.5. Egypt Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
13.6.15.6. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
13.6.15.7. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.6.15.8. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.6.16. Rest of MEA
13.6.16.1. Overview
13.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
13.6.16.3. Rest of MEA Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
13.6.16.4. Rest of MEA Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
13.6.16.5. Rest of MEA Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
13.6.16.6. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
13.6.16.7. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13.6.16.8. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
14. Key Vendor Analysis- Infectious Disease Diagnostic Industry
14.1. Competitive Dashboard
14.2. Company Profiles
14.2.1. F. Hoffmann-La Roche Ltd.
14.2.2. Abbott
14.2.3. Biomérieux
14.2.4. Siemens Healthineers Ag
14.2.5. Danaher
14.2.6. Thermo Fisher Scientific Inc.
14.2.7. Hologic, Inc.
14.2.8. Becton, Dickinson And Company
14.2.9. Revvity
14.2.10. Qiagen
14.2.11. Seegene Inc.
14.2.12. Quidelortho Corporation
14.2.13. Grifols, S.A.
14.2.14. Diasorin S.P.A.
14.2.15. Bio-Rad Laboratories, Inc.
14.2.16. Sysmex Corporation
14.2.17. Others
15. 360 Degree Analyst View
16. Appendix
16.1. Research Methodology
16.2. References
16.3. Abbreviations
16.4. Disclaimer
16.5. Contact Us
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
